Skip to main content

Table 2 Four types of dysregulated pairs of lncRNA-PCG in AT/RT vs. Brain, KRT vs. Kidney and AT/RT vs. KRT

From: Identification of RPL5 and RPL10 as novel diagnostic biomarkers of Atypical teratoid/rhabdoid tumors

AT/RT vs. Brain

Brain

AT/RT

Type

AllPCG

DiffPCG

CancerG

Yes

No

I

66,125

18,651

2629

No

Yes

II

3059

232

138

Positive

Nagetive

III

16

4

2

Nagetive

Positive

IV

36

2

4

KRT vs. Kidney

Kidney

KRT

Type

AllPCG

DiffPCG

CancerG

Yes

No

I

16,408

6259

675

No

Yes

II

28,350

7371

1284

Positive

Nagetive

III

260

100

12

Nagetive

Positive

IV

157

35

5

AT/RT vs. KRT

AT/RT

KRT

Type

AllPCG

DiffPCG

CancerG

Yes

No

I

5543

776

263

No

Yes

II

45,245

6908

1742

Positive

Nagetive

III

53

2

5

Nagetive

Positive

IV

21

3

1

  1. Co-expressed pair were classified into four types, based on presence and type of regulation of the co-expression in the three sets of comparisons, namely (A) AT/RT vs normal brain samples, (B) KRT vs normal kidney samples, and (C) AT/RT vs KRT samples. Type I: co-expressed pairs that were present in AT/RT (A), KRT (B), and AT/RT (C), and absent in normal brain samples (A), normal kidney samples (B), and KRT(C). Type II: co-expressed pairs that were absent in AT/RT (A), KRT (B), and AT/RT (C), and was present in the corresponding control samples. Type III: co-expression pairs that were positively co-expressed in AT/RT (A), KRT (B), and AT/RT (C) and negatively co-expressed in the corresponding control samples. Type IV: co-expression pairs that were negatively co-expressed in AT/RT (A), KRT (B), and AT/RT (C) and positively co-expressed in the corresponding control samples